X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dermatology (59) 59
humans (56) 56
index medicus (49) 49
male (40) 40
female (39) 39
adult (34) 34
middle aged (31) 31
aged (24) 24
psoriasis (22) 22
therapy (13) 13
prevalence (12) 12
retrospective studies (12) 12
adolescent (11) 11
aged, 80 and over (11) 11
infliximab (11) 11
quality of life (11) 11
skin (11) 11
skin diseases (11) 11
young adult (11) 11
care and treatment (10) 10
severity of illness index (10) 10
follow-up studies (9) 9
risk factors (9) 9
atopic dermatitis (8) 8
disease (8) 8
france (8) 8
life sciences (8) 8
patients (8) 8
prospective studies (8) 8
association (7) 7
child (7) 7
comorbidity (7) 7
multicenter (7) 7
risk (7) 7
time factors (7) 7
adults (6) 6
antibodies, monoclonal - therapeutic use (6) 6
bullous pemphigoid (6) 6
cross-sectional studies (6) 6
double-blind (6) 6
etanercept (6) 6
france - epidemiology (6) 6
inflammation (6) 6
medical treatment (6) 6
rheumatology (6) 6
severity (6) 6
adalimumab (5) 5
biopsy (5) 5
burden (5) 5
child, preschool (5) 5
drug eruptions - etiology (5) 5
epidemiology (5) 5
management (5) 5
medicine & public health (5) 5
psoriasis - epidemiology (5) 5
questionnaires (5) 5
receptor, epidermal growth factor - antagonists & inhibitors (5) 5
rheumatoid-arthritis (5) 5
rituximab (5) 5
skin neoplasms - pathology (5) 5
abridged index medicus (4) 4
acne (4) 4
age of onset (4) 4
antineoplastic agents - therapeutic use (4) 4
atopic (4) 4
cetuximab (4) 4
complications and side effects (4) 4
dermatitis (4) 4
dermatologic agents - therapeutic use (4) 4
eczema (4) 4
enzyme-linked immunosorbent assay (4) 4
hidradenitis suppurativa (4) 4
methotrexate (4) 4
monoclonal antibodies (4) 4
myocardial-infarction (4) 4
oncology (4) 4
psoriasis - drug therapy (4) 4
rash (4) 4
risk-factors (4) 4
safety (4) 4
skin - pathology (4) 4
treatment outcome (4) 4
tumor necrosis factor-alpha - antagonists & inhibitors (4) 4
urticaria (4) 4
adrenal cortex hormones - therapeutic use (3) 3
alpha (3) 3
analysis (3) 3
angioedema (3) 3
antibodies, monoclonal - adverse effects (3) 3
antihistamines (3) 3
antineoplastic agents - adverse effects (3) 3
arthritis (3) 3
autoantibodies - blood (3) 3
autoantibodies - immunology (3) 3
autoantigens - immunology (3) 3
cancer (3) 3
childhood (3) 3
comorbidities (3) 3
cytokines (3) 3
dermatitis, atopic - diagnosis (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, ISSN 0151-9638, 12/2017, Volume 144, pp. S15 - S22
Atopic dermatitis (DA) is a chronic inflammatory skin disease. Its incidence and prevalence is increasing, especially in industrialized countries. The... 
CRITERIA | Atopic Dermatitis | RISK-FACTORS | QUALITY | Eczema | DISEASE | NATIONAL-HEALTH | Adult-onset atopic dermatitis | ONSET | FEATURES | DERMATOLOGY | Dermatitis, Atopic - diagnosis | Adult | Diagnosis, Differential | Comorbidity | Dermatitis, Atopic - complications | Humans
Journal Article
Annales de Dermatologie et de Venereologie, ISSN 0151-9638, 12/2017, Volume 144, pp. VS15 - VS22
Atopic dermatitis (DA) is a chronic inflammatory skin disease. Its incidence and prevalence is increasing, especially in industrialized countries. The... 
Atopic Dermatitis | Adult-onset atopic dermatitis | Eczéma
Journal Article
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 10/2017, Volume 137, Issue 10, pp. S211 - S211
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 01/2019, Volume 180, Issue 1, pp. e14 - e14
Summary This study from France concerned itself with the biologic drug, omalizumab, as treatment for chronic spontaneous urticaria (CSU). CSU causes... 
Antihistamines | Stings | Urticaria | Immunotherapy | Angioedema | Immunoglobulin E | Monoclonal antibodies | Drug resistance | Patients | Quality of life
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 01/2019, Volume 180, Issue 1, pp. e27 - e27
Summary 这项来自法国的研究本身关注生物药奥玛朱单抗作为慢性自发性荨麻疹 (CSU) 的治疗。CSU 导致棘手(甚至致人衰弱)的瘙痒性鞭痕样荨麻刺伤(荨麻疹)以及通常影响口唇、舌和眼睑等较深部组织的肿胀(血管性水肿)。奥马珠单抗被批准用于对高剂量抗组胺药无效的重度 CSU。入组了 136名 CSU 患者,124... 
Antihistamines | Urticaria | Angioedema | Immunoglobulin E | Monoclonal antibodies | Patients | Quality of life | Pharmaceuticals
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 01/2019, Volume 180, Issue 1, pp. 56 - 66
Summary Background Omalizumab is approved as an add‐on therapy for the treatment of chronic spontaneous urticaria (CSU) in patients with inadequate response to... 
REVISION | ACTIVATION | MANAGEMENT | PLASMA | DISEASE | COAGULATION | D-DIMER | DERMATOLOGY | Edema | Antihistamines | Effectiveness | Urticaria | Angioedema | Clinical trials | Patient safety | Immunoglobulin E | Monoclonal antibodies | Patients | Disease control
Journal Article
Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, ISSN 1098-3015, 10/2017, Volume 20, Issue 9, p. A943
OBJECTIVES: Atopic dermatitis (AD) is a disease with a high burden and impact on quality of life. To date only a few studies have been conducted evaluating the... 
Activities of daily living | Dermatology | Medical treatment | Severity | Burden | Dermatitis | Quality of life | Atopic | Atopic dermatitis | Sexuality | Childhood | Questionnaires | Skin diseases | Adults | Children
Journal Article
Value in Health, ISSN 1098-3015, 10/2017, Volume 20, Issue 9, pp. A943 - A943
Journal Article
Value in Health, ISSN 1098-3015, 10/2017, Volume 20, Issue 9, p. A943
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue Suppl 2, pp. 1159 - 1159
BackgroundHidradenitis suppurative (HS) is a chronic inflammatory disease that results in abcesses, keloids and fistula. If the association between Crohn's... 
Journal Article
Value in Health, ISSN 1098-3015, 10/2018, Volume 21, pp. S435 - S435
Journal Article